Back to results
US 2021/0061874 A1Published application
Claudin-6 peptides
OwnerAlex POWLESLAND, Mei SUNinventors
Life of this patent
Estimating the term…
Abstract
The present invention relates to novel peptides derived from Claudin-6 (CLDN6), complexes comprising such peptides bound to recombinant MHC molecules, and cells presenting said peptide in complex with MHC molecules. Also provided by the present invention are binding moieties that bind to the peptides and/or complexes of the invention. Such moieties are useful for the development of immunotherapeutic reagents for the treatment of diseases such as cancer.
Claims20
A polypeptide comprising:
- (i) the amino acid sequence SLLALPQDLQA (SEQ ID NO:
- 1);
- (ii) the amino acid sequence VLTSGIVFV (SEQ ID NO:
- 2);
- (iii) the amino acid sequence TLIPVCWTA (SEQ ID NO:
- 3);
- (iv) the amino acid sequence AISRGPSEYPTKNYV (SEQ ID NO:
- 4);
- (v) the amino acid sequence GLLLLGGGL (SEQ ID NO:
- 5);
- or
- (vi) the amino acid sequence of SEQ ID NOs:
- 1-5 with the exception of 1, 2 or 3 amino acid substitutions, and/or 1, 2 or 3 amino acid insertions, and/or 1, 2 or 3 amino acid deletions,
- wherein the polypeptide is capable of forming a complex with a Major Histocompatibility Complex (MHC) molecule.
11 more elements
Dependencies are inferred from the claim text.